Therapeutics Ocumension

Affiliations

  • Director at Eyepoint Pharmaceuticals Inc. (EYEP), 2024-01-16
  • Large Shareholder at Alimera Sciences Inc (ALIM), 2021-04-30
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EYEP $19.45 1,910,500 $37,159,225.00 100,221 2024-01-11 Filing
EYEP $18.41 266,242 $4,901,515.22 2,010,721 2023-12-06 Filing
EYEP $19.91 733,758 $14,609,121.78 2,276,963 2023-12-05 Filing